According to the company statement, Barber-Lui will lead the process to identify a new Board Chair and engage with shareholders to gather input on criteria and board evolution. "Raju has been an integral part of PureTech's journey for almost two decades," said Bharatt Chowrira, PhD, JD, PureTech's Chief Executive Officer, in the press release. Robert Langer, ScD, PureTech's Co-founder and board member, noted that Dr. Kucherlapati helped guide PureTech from its startup phase into an established biotherapeutics company. During his tenure, PureTech developed a portfolio of 29 therapeutics and therapeutic candidates, including three that have received FDA approval. The company's most recently FDA-approved product is Cobenfy.